Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 204676 | ||
| 12:40 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure--
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Enzon to Release Third Quarter 2008 Earnings on Wednesday, November 5, 2008; Conference Call and Webcast to Follow
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow

Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
Enzon Announces IND Acceptance for its Survivin Antagonist
-- Phase I study to open for patients with solid tumors--
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business --
